Brain Neoplasms, Malignant: Clinical Trials

1 trial for Brain Neoplasms, Malignant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Brain Neoplasms, Malignant: new trials by email Literature Review of Brain Neoplasms, Malignant trials Research Report on Brain Neoplasms, Malignant

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CEST- Glucose Enhanced MRI for Metastatic Brain Tumours
Magnetic resonance imaging, Gadovist (Gadobutrol), 50% dextrose solution - Brain Neoplasms, Malignant, Metastasis
Phase 2TerminatedBritish Columbia Cancer Agency32016-10-012019-01-28

Narrower conditions

Brain Neoplasms (1)  ·  Neoplasm Metastasis (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Neoplastic Processes (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Magnetic Resonance Spectroscopy (1)  ·  gadobutrol (1)

Sponsors

British Columbia Cancer Agency (1)

Countries

Canada (1)

Top investigators

Michael McKenzie (1)